Status:

COMPLETED

Post-biotic Intervention for Acute Stress Management

Lead Sponsor:

Institute for Human Development and Potential (IHDP), Singapore

Conditions:

Stress Response

Mood State

Eligibility:

MALE

21-30 years

Phase:

NA

Brief Summary

The study aims to evaluate the sub-chronic effects of colonic delivery of a post-biotic on stress response, mood state, sleep, and cognition in healthy young subjects with elevated self-reported stres...

Detailed Description

Scientific findings over the past years suggest that certain bacteria in our gastrointestinal system have an influence on our mood, although, the mechanisms are not yet well understood. One of the pos...

Eligibility Criteria

Inclusion

  • Aged 21 to 30 years
  • Men
  • Perceived Stress Scale (PSS-10) score \>13
  • Own and uses a smartphone that is capable to run the study applications with access to the internet
  • Adequate fluency in the English language to understand the inform consent process, study instructions and study assessments
  • Sufficient vision and hearing to complete study procedures
  • Willing to commit to the study procedures
  • Willing and able to participate and to give written informed consent All inclusion criteria will be assessed based on self-reported information during the screening visit.

Exclusion

  • Past (\< 6 months prior to the study) or current major neurological, psychiatric, gastrointestinal, metabolic disease or cardiovascular disease
  • Past (\<1 months prior to the study) or current use of psychoactive medication, cardiovascular medication, or corticosteroids.
  • Known medical history of hypotension or currently on antihypertensive medication
  • Alcohol intake \>1 units day
  • Present or past history of alcohol or drug addiction and/or recreational drug use
  • BMI \<18.5 or \>25 kg/m2
  • Maltodextrin allergy
  • Members of the research team or their immediate family members. An immediate family member is defined as spouse, parent, child, or sibling, whether biological or legally adopted All exclusion criteria will be assessed based on self-reported information during the screening call.

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 14 2024

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT06097182

Start Date

November 1 2023

End Date

June 14 2024

Last Update

August 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Human Development Research Centre, SICS, A*STAR

Singapore, Singapore, 117597